Skip to main content

Home/ Dr. Goodyear/ Group items tagged ESR

Rss Feed Group items tagged

Nathan Goodyear

ESR1 Mutations in Breast Cancer - 0 views

  •  
    ESR1 mutation a result of AI resistance.
Nathan Goodyear

Influence of Testosterone Therapy on Clinical and Immunological Features of Autoimmune ... - 0 views

  •  
    Testosterone therapy in men with Sjogren's disease and Lupus reduces inflammation (ESR, RF, ANA).  In fact, clinical remission was noted in all patients.
Nathan Goodyear

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic... - 0 views

  • orally active competitive opioid receptor antagonist
  • 4.5 mg, though the dosage can vary a few milligrams below or above that common value
  • At the low dosage level, naltrexone exhibits paradoxical properties, including analgesia and anti-inflammatory actions
  • ...10 more annotations...
  • LDN may be an effective treatment for FM
  • In addition to the antagonist effect on mu-opioid and other opioid receptors, naltrexone simultaneously has an antagonist effect on non-opioid receptors (Toll-like receptor 4 or TLR4) that are found on macrophages such as microglia
  • It is via the non-opioid antagonist path that LDN is thought to exert its anti-inflammatory effects
  • Once activated, microglia produce inflammatory and excitatory factors that can cause sickness behaviors such as pain sensitivity, fatigue, cognitive disruption, sleep disorders, mood disorders, and general malaise
  • The neuroprotective action appears to result when microglia activation in the brain and spinal cord is inhibited
  • By suppressing microglia activation, naloxone reduces the production of reactive oxygen species and other potentially neuroexcitatory and neurotoxic chemicals
  • suppressed TNF-alpha, IL-6, MCP-1, and other inflammatory agents in peripheral macrophages
  • individuals with greater ESR at baseline experienced a greater drop in pain when taking LDN
  • LDN has been reported to reduce not only self-reported pain in that condition but also objective markers of inflammation and disease severity
  • Naltrexone has also shown some promise in improving disease severity in multiple sclerosis
  •  
    LDN maybe useful in treating chronic pain via anti-inflammatory effects on microglia.
1 - 7 of 7
Showing 20 items per page